LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Recruiting now
Conditions studied: Liver Inflammation, Fatty Liver Disease
In brief
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
Key facts
- Study ID
- NCT06802731
- Run by
- Wuxi Hisky Medical Technology Co Ltd
- People needed
- 365
- Starts
- 2024-01-01
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2025-01-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;
- Age over 18 years old, gender not limited;
- Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease);
- Perform iLivTouch examination within ± 14 days of liver pathology examination;
- No history of excessive alcohol consumption (converted to ethanol:<140g/week for males,<70g/week for females);
Where it is running
- Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.